138 related articles for article (PubMed ID: 35330345)
1. Metastatic Pattern of Truncal and Extremity Leiomyosarcoma: Retrospective Analysis of Predictors, Outcomes, and Detection.
Tigchelaar SS; Frey C; Sivaraj D; Segovia NA; Mohler DG; Steffner RJ; Avedian RS
J Pers Med; 2022 Feb; 12(3):. PubMed ID: 35330345
[TBL] [Abstract][Full Text] [Related]
2. A closer look at the natural history and recurrence patterns of high-grade truncal/extremity leiomyosarcomas: A multi-institutional analysis from the US Sarcoma Collaborative.
Lee RM; Ethun CG; Zaidi MY; Tran TB; Poultsides GA; Grignol VP; Howard JH; Bedi M; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Oskouei SV; Monson DK; Reimer NB; Maithel SK; Cardona K
Surg Oncol; 2020 Sep; 34():292-297. PubMed ID: 32891345
[TBL] [Abstract][Full Text] [Related]
3. Leiomyosarcoma of the urinary bladder: A SEER database study and comparison to leiomyosarcomas of the uterus and extremities/trunk.
Coiner BL; Cates J; Kamanda S; Giannico GA; Gordetsky JB
Ann Diagn Pathol; 2021 Aug; 53():151743. PubMed ID: 33964611
[TBL] [Abstract][Full Text] [Related]
4. Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
Worhunsky DJ; Gupta M; Gholami S; Tran TB; Ganjoo KN; van de Rijn M; Visser BC; Norton JA; Poultsides GA
J Surg Oncol; 2015 Jun; 111(7):808-12. PubMed ID: 25920434
[TBL] [Abstract][Full Text] [Related]
5. Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma.
Lamm W; Natter C; Schur S; Köstler WJ; Reinthaller A; Krainer M; Grimm C; Horvath R; Amann G; Funovics P; Brodowicz T; Polterauer S
BMC Cancer; 2014 Dec; 14():981. PubMed ID: 25523155
[TBL] [Abstract][Full Text] [Related]
6. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
[TBL] [Abstract][Full Text] [Related]
7. Imaging features and metastatic pattern of non-IVC retroperitoneal leiomyosarcomas: are they different from IVC leiomyosarcomas?
Cooley CL; Jagannathan JP; Kurra V; Tirumani SH; Saboo SS; Ramaiya NH; Shinagare AB
J Comput Assist Tomogr; 2014; 38(5):687-92. PubMed ID: 24834891
[TBL] [Abstract][Full Text] [Related]
8. MRI, MDCT features, and clinical outcome of extremity leiomyosarcomas: experience in 47 patients.
Gordon RW; Tirumani SH; Kurra V; Shinagare AB; Jagannathan JP; Hornick JL; Ramaiya NH
Skeletal Radiol; 2014 May; 43(5):615-22. PubMed ID: 24496586
[TBL] [Abstract][Full Text] [Related]
9. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
[TBL] [Abstract][Full Text] [Related]
10. Value of 18F-FDG PET/CT imaging in the staging, restaging, monitoring of response to therapy and surveillance of uterine leiomyosarcomas.
Bélissant O; Champion L; Thevenet H; Weinmann P; Alberini JL
Nucl Med Commun; 2018 Jul; 39(7):652-658. PubMed ID: 29683931
[TBL] [Abstract][Full Text] [Related]
11. Leiomyoma and Leiomyosarcoma (Primary and Metastatic) of the Oral and Maxillofacial Region: A Clinicopathological and Immunohistochemical Study of 27 Cases.
de Araújo GR; Costa SFDS; Mesquita RA; Gomez RS; Dos Santos JN; Pontes HAR; de Andrade BAB; Romañach MJ; Agostini M; Vargas PA; de Cáceres CVBL; Santos-Silva AR; Ribeiro ACP; Brandão TB; Tomasi RA; Ferreyra RS; de Almeida OP; Fonseca FP
Head Neck Pathol; 2022 Mar; 16(1):294-303. PubMed ID: 34106410
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.
Ethun CG; Lopez-Aguiar AG; Switchenko JM; Gillespie TW; Delman KA; Staley CA; Maithel SK; Cardona K
Ann Surg Oncol; 2019 Dec; 26(13):4723-4729. PubMed ID: 31502023
[TBL] [Abstract][Full Text] [Related]
13. Bone Metastases in Patients with Leiomyosarcoma: A Retrospective Analysis of Survival and Surgical Management.
LiBrizzi CL; Vankara A; Meyer CF; Levin AS; Morris CD
Sarcoma; 2022; 2022():6806932. PubMed ID: 35570847
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
15. Surgery plus chemotherapy improves survival of patients with extremity soft tissue leiomyosarcoma and metastasis at presentation.
Qian SJ; Wu JQ; Wang Z; Zhang B
J Cancer; 2019; 10(10):2169-2175. PubMed ID: 31258720
[No Abstract] [Full Text] [Related]
16. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
[TBL] [Abstract][Full Text] [Related]
17. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas.
Rao UN; Finkelstein SD; Jones MW
Mod Pathol; 1999 Nov; 12(11):1001-9. PubMed ID: 10574596
[TBL] [Abstract][Full Text] [Related]
18. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
[TBL] [Abstract][Full Text] [Related]
19. Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients.
Tirumani SH; Deaver P; Shinagare AB; Tirumani H; Hornick JL; George S; Ramaiya NH
J Gynecol Oncol; 2014 Oct; 25(4):306-12. PubMed ID: 25142630
[TBL] [Abstract][Full Text] [Related]
20. Distant Metastases in Uterine Leiomyosarcomas: The Wide Variety of Body Sites and Time Intervals to Metastatic Relapse.
Bartosch C; Afonso M; Pires-Luís AS; Galaghar A; Guimarães M; Antunes L; Lopes JM
Int J Gynecol Pathol; 2017 Jan; 36(1):31-41. PubMed ID: 27015437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
